Radiology Business July 26, 2024
Marty Stempniak

Hologic Inc. has finalized its acquisition of a rival breast care company for $310 million, the Marlborough, Massachusetts, mammography system-maker announced Thursday.

Endomagnetics Ltd. is a developer of breast surgery localization and lymphatic tracing technologies. Based in Cambridge, U.K., the private company generated about $35 million in revenue last year.

“With our shared commitment to advancing women’s health globally, we are excited to improve outcomes for patients and, together with our customers, redefine the standard of care for breast cancer intervention,” Erik Anderson, president of Breast and Skeletal Health Solutions at publicly traded Hologic, said in a July 25 announcement.

Products joining the Hologic brand include the Magseed marker for magnetic tissue localization before surgery. Endomag also offers the Magtrace...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Medical Devices, Mergers & Acquisitions / JV, Trends
UN warns of military brain control
Only 20% of AI devices for children used pediatric data to train: 3 notes
Medtech firms have cut thousands of jobs this year. Will layoffs continue in 2025?
Proton therapy market in the US projected to reach $2.67 billion by 2033
How Trump’s second term will affect the medtech industry

Share This Article